These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32446873)

  • 81. Biophysical and molecular docking approaches for the investigation of biomolecular interactions between amphotericin B and bovine serum albumin.
    Raza M; Ahmad A; Yue F; Khan Z; Jiang Y; Wei Y; Raza S; He WW; Khan FU; Qipeng Y
    J Photochem Photobiol B; 2017 May; 170():6-15. PubMed ID: 28364684
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
    Tiyaboonchai W; Limpeanchob N
    Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents.
    Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A
    Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Improved antifungal activity of amphotericin B-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.
    Tang X; Jiao R; Xie C; Xu L; Huo Z; Dai J; Qian Y; Xu W; Hou W; Wang J; Liang Y
    Int J Clin Exp Med; 2015; 8(4):5150-62. PubMed ID: 26131089
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia.
    Ali I; Sharma P; Suri KA; Satti NK; Dutt P; Afrin F; Khan IA
    J Med Microbiol; 2011 Sep; 60(Pt 9):1326-1336. PubMed ID: 21474610
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Amphotericin B-PEG Conjugates of ZnO Nanoparticles: Enhancement Antifungal Activity with Minimal Toxicity.
    Alshahrani SM; Khafagy ES; Riadi Y; Al Saqr A; Alfadhel MM; Hegazy WAH
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015271
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Amphotericin B Tamed by Salicylic Acid.
    Yu Y; Chen P; Gao M; Lan W; Sun S; Ma Z; Sultani R; Cui Y; Umar MN; Khan SW; Cai X; Liang Z; Tan H
    ACS Omega; 2022 May; 7(17):14690-14696. PubMed ID: 35557655
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole.
    Udawatte NS; Kang SW; Wang Y; Arumugam TV; Seneviratne CJ
    Front Pharmacol; 2020; 11():511. PubMed ID: 32390849
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections.
    Cheng L; Niu MM; Yan T; Ma Z; Huang K; Yang L; Zhong X; Li C
    Acta Pharm Sin B; 2021 Oct; 11(10):3220-3230. PubMed ID: 34729311
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antibiotics armed neutrophils as a potential therapy for brain fungal infection caused by chemotherapy-induced neutropenia.
    Han Y; Liu Y; Ma X; Shen A; Liu Y; Weeranoppanant N; Dong H; Li Y; Ren T; Kuai L; Li B; An M; Li Y
    Biomaterials; 2021 Jul; 274():120849. PubMed ID: 34022739
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid.
    Salama S; Rotstein C
    Can J Infect Dis; 1997 May; 8(3):157-60. PubMed ID: 22514488
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Preventing
    Chen SM; Zou Z; Guo SY; Hou WT; Qiu XR; Zhang Y; Song LJ; Hu XY; Jiang YY; Shen H; An MM
    Emerg Microbes Infect; 2020 Dec; 9(1):2417-2432. PubMed ID: 33115324
    [No Abstract]   [Full Text] [Related]  

  • 93. Dectin-1 Facilitates IL-18 Production for the Generation of Protective Antibodies Against
    Shen H; Yu Y; Chen SM; Sun JJ; Fang W; Guo SY; Hou WT; Qiu XR; Zhang Y; Chen YL; Wang YD; Hu XY; Lu L; Jiang YY; Zou Z; An MM
    Front Microbiol; 2020; 11():1648. PubMed ID: 32765468
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Regulation of renal nitric oxide and eNOS/iNOS expression by tadalafil participates in the mitigation of amphotericin B-induced renal injury: Down-regulation of NF-κB/iNOS/caspase-3 signaling.
    Abdel-Rahman DM; Messiha BAS; Ali FEM; Azouz AA
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3141-3153. PubMed ID: 37891258
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparative Colloidal Stability of Commercial Amphotericin B Nanoformulations Using Dynamic and Static Multiple Light Scattering Techniques.
    Ye J; Li R; Cheng J; Liu D; Yang Y; Wang H; Xu X; Li L; Ma P; Liu Y
    Int J Nanomedicine; 2022; 17():6047-6064. PubMed ID: 36510621
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Bibliometric and visual analysis of nephrotoxicity research worldwide.
    He T; Ao J; Duan C; Yan R; Li X; Liu L; Zhang J; Li X
    Front Pharmacol; 2022; 13():940791. PubMed ID: 36188597
    [No Abstract]   [Full Text] [Related]  

  • 98. Application of berberine-loaded albumin nanoparticles in infections of traumatic wounds.
    Liu Z; Liu Y; Fang T; Xia J; Ma N; Wang Y
    Int J Burns Trauma; 2022; 12(1):28-34. PubMed ID: 35309105
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evaluation of the
    Zhang Y; Liu YC; Chen SM; Zong H; Hou WT; Qiu XR; Guo SY; Sun YF; Jiang YY; An MM; Shen H
    Front Microbiol; 2021; 12():788442. PubMed ID: 34970244
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.